Australia markets closed

Pulse Biosciences Inc (6L8.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
7.35-0.05 (-0.68%)
At close: 07:26PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
700
1,418
0
Cost of revenue
0
0
11,944
1,968
0
Gross profit
0
0
-11,244
-550
0
Operating expenses
Research development
27,797
27,797
20,839
28,640
26,444
Selling general and administrative
15,777
15,777
25,974
33,824
23,521
Total operating expenses
43,574
43,574
46,813
62,464
49,965
Operating income or loss
-43,574
-43,574
-58,057
-63,014
-49,965
Income before tax
-42,210
-42,210
-58,505
-63,660
-49,851
Income tax expense
0
0
0
0
0
Income from continuing operations
-42,210
-42,210
-58,505
-63,660
-49,851
Net income
-42,210
-42,210
-58,505
-63,660
-49,851
Net income available to common shareholders
-42,210
-42,210
-58,505
-63,660
-49,851
Basic EPS
-1.72
-0.88
-1.72
-2.28
-2.14
Diluted EPS
-1.72
-0.88
-1.72
-2.28
-2.14
Basic average shares
33,935
48,038
33,935
27,964
23,248
Diluted average shares
33,935
48,038
33,935
27,964
23,248